Description

The program funds innovative, patient-focused interventional clinical trials (Phase I–III) in cancer, aiming to expand treatment options and improve the quality of life for patients globally. Grants are open to academic and not-for-profit institutions, supporting research that advances cancer detection, treatment, or implementation strategies. The program does not support basic research, Phase IV trials, or observational studies, focusing solely on projects that directly test interventions in clinical settings. Patient partner involvement in study protocol design is encouraged, and pre-application grants are available to facilitate patient engagement in the development of proposals.